Optimize the diagnostic pathway with a fully-automated, single procedure that easily distinguishes between bacterial and viral infections in less than an hour.
Multi-step workflow required
Prolonged time to results
Risk of antibiotic misuse
Limited sensitivity and specificity
Uncertainty regarding severity
Lack of automated testing procedures
LIAISON® MeMed BV® helps you provide accurate answers while meeting clinical and emergency department timelines
LIAISON® MeMed BV® is a high-quality chemiluminescent assay that runs on the LIAISON® platforms
npv* : Negative Predictive Value
***Measures of Sensitivity, Specificity and Negative Predictive Value (NPV) have been calculated by considering a bacterial result as positive and a viral/other result as negative.
The speed and precision of our high-throughput, high-quality CLIA test delivers reliable and easy-to-interpret diagnostic results in a single procedure. And because LIAISON® is a fully-automated immunoassay analyzer, it lets you optimize time and resources while delivering high-quality results to the consulting clinicians.
News and events
“Bacterial or Viral? The added value of an innovative diagnostic solution for responsiveness when facing clinical uncertainties” available from 29.11.22
“LIAISON® MeMed BV®: a powerful diagnostic solution for the quick and easy differentiation of infection etiology” presented at 7th National Congress of Laboratory Medicine, which was held in Italy October 17th to 19th 2022
“Evaluation of LIAISON® MeMed BV® to discriminate bacterial and viral infections”
presented at the 27° Simposio annuale ELAS Italia – LIGAND ASSAY 2022 held on 21-23 November in Bologna, Italy